(Updated - October 22, 2021 6:06 AM EDT)Deutsche Bank analyst Emmanuel Papadakis initiates coverage on Moderna (NASDAQ: MRNA) with a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Hot Comments Hot New Coverage New Coverage

Moderna (MRNA) Enters MOU to Supply up to 110M COVID-19 Vaccine Doses to the African UnionOctober 26, 2021 5:50 AM CDC Advisory Committee Recommends Booster Shot of Moderna's (MRNA) COVID-19 VaccineOctober 22, 2021 5:40 AM U.S. CDC Advisory Committee on Immunization Practices Recommends Booster Vaccination with Moderna’s COVID-19 VaccineOctober 21, 2021 5:49 PM CDC Advisers Back Moderna (MRNA) Booster for Older, at Risk Groups - BloombergOctober 21, 2021 5:14 PM Moderna (MRNA) Shares Tick Lower as White House Seeks WTO Support for Vaccine IP WaiverOctober 21, 2021 2:50 PM Moderna (MRNA) Mix & Match Approval Means Booster Can Follow Any Other Vaccine - Piper Sandler October 21, 2021 9:20 AM Moderna (MRNA) IV into COVID-19 vaccine boosters get FDA authorizationOctober 21, 2021 4:31 AM FDA Takes Action to Expand the Use of a Booster Dose for Moderna and Janssen COVID-19 VaccinesOctober 20, 2021 5:54 PM Moderna (MRNA) Confirms FDA Authorization of Booster Dose of its COVID-19 Vaccine in the U.S.October 20, 2021 5:38 PM Moderna Announces FDA Authorization of a Booster Dose of Moderna’s COVID-19 Vaccine in the U.S.October 20, 2021 5:37 PM U.S. FDA clears Moderna, J&J COVID-19 boosters, backs use of different vaccine for boostOctober 20, 2021 5:02 PM Moderna (MRNA), J&J (JNJ) Vaccine Booster EUAs Approved by FDA, Along with "Mix and Match" Booster DosesOctober 20, 2021 4:50 PM